We are live on ! Find out more
BFO

Boston Family Office Portfolio holdings

AUM $1.5B
1-Year Est. Return 11.68%
This Fund
S&P 500
This Quarter Est. Return
+15.63%
1 Year Est. Return
+11.68%
3 Year Est. Return
+44.44%
5 Year Est. Return
+55.04%
10 Year Est. Return
+258.3%
AUM
$925M
AUM Growth
+$121M
Cap. Flow
-$1.06M
Cap. Flow %
-0.11%
Top 10 Hldgs %
22.31%
Holding
255
New
7
Increased
77
Reduced
98
Closed
5

Top Buys

Rank Stock Value
1
APD icon
Air Products & Chemicals
APD
+$6.4M
2
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$2.73M
3
CVS icon
CVS Health
CVS
+$2.43M
4
MSFT icon
Microsoft
MSFT
+$2.14M
5
V icon
Visa
V
+$1.6M

Top Sells

Rank Stock Value
1
LIN icon
Linde
LIN
+$7.75M
2
CELG
Celgene Corp
CELG
+$5.4M
3
AL
Air Lease Corp
AL
+$2.84M
4
AMT icon
American Tower
AMT
+$1.93M
5
KMI icon
Kinder Morgan
KMI
+$1.36M

Sector Composition

Rank Sector Weight
1 Healthcare 16.89%
2 Technology 16.36%
3 Industrials 11.15%
4 Consumer Staples 8.91%
5 Financials 8.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VEU icon
76
Vanguard FTSE All-World ex-US ETF
VEU
$68.5B
$3.42M 0.37%
68,207
-561
-0.8% -$27.5K
NSC icon
77
Norfolk Southern
NSC
$75.1B
$3.39M 0.37%
18,123
-15
-0.1% -$2.59K
CMCSA icon
78
Comcast
CMCSA
$90B
$3.36M 0.36%
83,986
+2,189
+3% +$82.4K
NEOG icon
79
Neogen
NEOG
$2.5B
$3.35M 0.36%
116,758
+6,726
+6% +$203K
D icon
80
Dominion Energy
D
$59.3B
$3.27M 0.35%
42,631
– –
SRCL
81
DELISTED
Stericycle Inc
SRCL
$3.22M 0.35%
59,095
-4,000
-6% -$181K
ORCL icon
82
Oracle
ORCL
$423B
$3.1M 0.34%
57,790
-19,775
-25% -$1.01M
XYL icon
83
Xylem
XYL
$28.1B
$3.03M 0.33%
38,361
+9,675
+34% +$706K
WY icon
84
Weyerhaeuser
WY
$18.4B
$2.99M 0.32%
113,469
-1,656
-1% -$41.7K
GOOGL icon
85
Alphabet (Google) Class A
GOOGL
$4.33T
$2.9M 0.31%
49,300
– –
DIS icon
86
Walt Disney
DIS
$181B
$2.85M 0.31%
25,666
+659
+3% +$73.7K
PH icon
87
Parker-Hannifin
PH
$135B
$2.77M 0.3%
16,121
– –
IBM icon
88
IBM
IBM
$224B
$2.75M 0.3%
20,420
-146
-0.7% -$18.6K
VIG icon
89
Vanguard Dividend Appreciation ETF
VIG
$114B
$2.5M 0.27%
22,774
+3,680
+19% +$388K
VXUS icon
90
Vanguard Total International Stock ETF
VXUS
$160B
$2.5M 0.27%
48,075
-1,890
-4% -$95.9K
WAB icon
91
Wabtec
WAB
$49.3B
$2.48M 0.27%
33,597
-14
-0% -$1.01K
FDX icon
92
FedEx
FDX
$75.4B
$2.47M 0.27%
13,637
+15
+0.1% +$2.65K
NVO
93
Novo Nordisk
NVO
$209B
$2.46M 0.27%
93,934
-804
-0.8% -$19.8K
CL icon
94
Colgate-Palmolive
CL
$74.4B
$2.33M 0.25%
34,055
-9,056
-21% -$585K
NVS icon
95
Novartis
NVS
$297B
$2.33M 0.25%
27,018
-249
-0.9% -$20K
IJH icon
96
iShares Core S&P Mid-Cap ETF
IJH
$127B
$2.27M 0.25%
60,020
+8,895
+17% +$328K
GLW icon
97
Corning
GLW
$143B
$2.25M 0.24%
67,992
-8,545
-11% -$280K
MDLZ icon
98
Mondelez International
MDLZ
$79.9B
$2.23M 0.24%
44,757
+134
+0.3% +$6.15K
DD icon
99
DuPont de Nemours
DD
$19.2B
$2.12M 0.23%
15,720
-131
-0.8% -$18.2K
THO icon
100
Thor Industries
THO
$4.14B
$2.12M 0.23%
33,974
-2,936
-8% -$186K
2 3
4
5 6

Similar funds

CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
AAM
Aureus Asset Management Boston, Massachusetts $1.5B AUM 20.3% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
NSGL
No Street GP LP San Francisco, California $1.5B AUM 34.53% 1-Year Est. Return
SGM
Seven Grand Managers Bronxville, New York $1.5B AUM 57.16% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
CPA
Capital Performance Advisors Walnut Creek, California $1.5B AUM 21.4% 1-Year Est. Return
MCM
Maple Capital Management Montpelier, Vermont $1.49B AUM 23.46% 1-Year Est. Return

Boston Family Office's Q1 2019 Portfolio in Review

As of Q1 2019, Boston Family Office held 255 positions worth $925M, up 15% from $804M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Trading was light in Q1 2019: portfolio turnover was 4.7%. Boston Family Office opened 7 new positions and exited 5, leaving the 255-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 18% a quarter earlier, followed by Technology and Industrials.

  • Boston Family Office's largest Q1 2019 buy was Enanta Pharmaceuticals: 2,750 shares worth $263K.
  • Boston Family Office added most to Air Products & Chemicals in Q1 2019, an estimated $6.4M increase.
  • Boston Family Office's biggest Q1 2019 reduction was Celgene Corp, cutting an estimated $5.4M.
  • Boston Family Office fully exited Linde in Q1 2019, selling an estimated $7.75M.
  • Boston Family Office's ten largest holdings make up 22% of its $925M portfolio in Q1 2019.
  • Boston Family Office opened 7 new positions and closed 5 in Q1 2019.
  • Boston Family Office's portfolio value rose 15% quarter-over-quarter to $925M.

Based on Boston Family Office's 13F filing for Q1 2019, filed 9 May 2019.